← Back to all signals
RESEARCH PAPER ANALYSIS

Is Rotationplasty Still a Reasonable Reconstruction Option for Patients With a Femoral Bone Sarcoma? A Comparative Study of Patients With a Minimum of 20 Years of Follow-up After Rotationplasty and Lower Extremity Amputation.

AI interpretation is pending for this paper.

Open original publication →
PMID40258173
JournalClinical orthopaedics and related research
Publication Date2025-04-17
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Rotationplasty was first introduced as an alternative to above-the-knee amputation after resection of bone sarcomas of the distal femur by Salzer in 1974. Although the procedure involves a substantial body image issue, it has many advantages such as durability of the reconstruction (compared with limb salvage procedures) and avoidance of phantom pain (compared with amputation). Although several reports have shown intermediate outcomes of rotationplasty, very long-term results in terms of function, activity levels, and quality of life (QoL) in comparison with above-the-knee amputation have not been reported. This work aims to fill this gap left by prior reports. QUESTIONS/PURPOSES: (1) Is there a difference in revision-free survival in very long-term follow-up after rotationplasty and transfemoral amputation or knee disarticulation? (2) Are patient activity levels after rotationplasty comparable with those after transfemoral amputation or knee disarticulation in the very long term? (3) Do activity levels differ in terms of QoL? (4) Within the group of patients who have undergone rotationplasty, is the ROM in the neo-knee associated with QoL 20 to 40 years later? METHODS: Between 1961 and 1995, a total of 360 patients were treated for bone and soft tissue sarcoma of the lower extremity. Fifty-four patients were treated with A1 rotationplasty, 124 were treated with an amputation, and 182 were treated with a limb salvage procedure. Of those who underwent amputation or rotationplasty, 9% (11 of 124) and 15% (8 of 54), respectively, were lost to follow-up before a period of 20 years without meeting a study endpoint, and another 71% (88 of 124) and 44% (24 of 54), respectively, died prior to 20 years with intact residual limbs, leaving 20% (25 of 124) and 41% (22 of 54), respectively, of the original group who had a follow-up time of at least 20 years. Four patients with amputations declined to participate in the study, while three patients with transtibial amputations and one patient with a complete language barrier after rotationplasty were excluded. These 39 patients with a minimum follow-up time of 20 years (mean [range] 36 years [23 to 55]) were available and gave their consent to this retrospective comparative study at the local orthopaedic department. The decision between rotationplasty and endoprosthetic replacement was made after thorough consultation and according to the patient's choice. As general guidance, Salzer's idea was to provide rotationplasty to patients who had a strong desire for higher levels of activity. Endoprosthetic reconstructions were more likely indicated given a patient's preference for a cosmetically uncompromised limb. Amputation was primarily performed one decade before the availability of rotationplasty and was mostly an alternative to rotationplasty because of patient refusal or surgical limitations. Therefore, the two groups differed in age at follow-up; however, they did not differ in age at surgery, BMI, gender ratio, tumor entities, or tumor localization. All-cause revisions presented in Kaplan-Meier curves, pain sensation, and functional and QoL outcomes, such as ROM, University of California Los Angeles (UCLA) activity scores, 5-level EuroQol 5-domain (EQ-5D-5L) scores, and 36-Item Short Form survey scores, were assessed. RESULTS: There was no difference between patients after rotationplasty and amputation in terms of survivorship free from revision of unpredictable events at 20 years (86% [95% confidence interval (CI) 85% to 95%] versus 67% [95% CI 64% to 94%]; p = 0.27). There was no difference in median UCLA activity scores between the groups (rotationplasty 6 versus amputation 5; p = 0.18). Patients treated with a rotationplasty had less pain than those treated with amputation (EQ-5D-5L pain/discomfort, p < 0.01). The EuroQol (EQ) index was higher in patients who had rotationplasty in comparison with patients who underwent amputation (0.92 versus 0.81; p = 0.01). A linear regression model that controlled for length of follow-up, gender, age, and type of surgery found that having rotationplasty was associated with a better EQ index than undergoing amputation (R = 0.538, R 2 corrected = 0.212; p = 0.011). There were positive correlations between the EQ index and both flexion (ρ = 0.53 [95% CI 0.03 to 0.82]; p = 0.03) and ROM (ρ = 0.54 [95% CI 0.05 to 0.82]; p = 0.03) in the neo-knee. CONCLUSION: After rotationplasty and amputation, patients show similarities at long-term follow-up in the use of external prostheses and in cosmetic issues after limb loss. Both groups might have benefitted from the advancements in prosthetics that have occurred and will continue to do so; however, in this study, patients seem to have better QoL after rotationplasty compared with those with amputation. This study intentionally did not compare outcomes after an extendible or modular endoprosthesis with outcomes after rotationplasty. However, failures after endoprosthetic reconstructions occur frequently in the long term, whereas they rarely exist after rotationplasty. The use of rotationplasty, therefore, might be a benefit not only to individual patients but also to stakeholders in healthcare systems. Furthermore, this study emphasizes the benefit of rotationplasty as a durable surgical method that enables patients for high physical performance. Therefore, tumor centers around the world should be aware of these benefits, and patients must be given the opportunity to receive information about it. Currently, rotationplasty might be beneficial in certain situations, at least when patients and/or parents accept this kind of reconstruction. Children younger than 5 to 7 years and small in height, patients considered for megaprostheses with borderline or insufficient soft tissue coverage, and even patients who are highly active and feel that sporting activities are most important for their lifestyle are potential candidates for rotationplasty. Furthermore, rotationplasty might be an option after failed limb salvage surgery. LEVEL OF EVIDENCE: Level III, therapeutic study.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Effects of nutritional intervention on insulin resistance-associated inflammatory biomarkers and gene polymorphisms in gestational diabetes mellitus. Journal of medical biochemistry 67.45 2 Factors influencing health-related quality of life in children with leukemia in Saudi Arabia: a cross- sectional study. BMC pediatrics 63.8 3 Breast Cancer Patients' Parenting Concerns User Personas: A Qualitative Analysis. Current oncology (Toronto, Ont.) 57.4 4 Molecular Pathogenesis, Tumor Microenvironment and Health Disparities in Select Pediatric Solid Tumors: An Integrative Narrative Review. Diseases (Basel, Switzerland) 65.5 5 Expression VIII: Final Results of the Individual Perception and Level of Information of Patients with Borderline Tumors of the Ovary. Current oncology (Toronto, Ont.) 67.8 6 Adolescents and young adults with cancer in Switzerland: a large retrospective single-centre cohort analysis of key care pathways and outcomes by sex and age. Swiss medical weekly 79.6 7 Cellular and Immunotherapy for Pediatric Brain Tumors: A Primer. Current oncology (Toronto, Ont.) 62.52 8 Exercise and Childhood Cancer: From Science to Life "The 3rd Pediatric Exercise Oncology Congress Meets FORTEe". Current oncology (Toronto, Ont.) 66.9 9 Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate-Induced Neurotoxicity and Ethnic Disparities. Cancer medicine 58.62 10 Two-Decade Trends in Radiotherapy Patterns and Clinical Outcomes for Soft Tissue Sarcoma: A Nationwide Study in South Korea (2005-2023). Cancer medicine 72.64 11 Re-resection at first recurrence is associated with prolonged survival in young patients with high-grade glioma: A multi-center study. Neuro-oncology advances 71.92 12 Risk Modulation by Electronic Cigarette Consumption in Cardiovascular Disease and Its Relevance in Cardiac Surgery-A Narrative Review. Journal of cardiovascular development and disease 55.0 13 Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review. Frontiers in endocrinology 86.1 14 Comparative efficacy and safety of pharmacologic, laser, and combination therapies for infantile hemangioma: a systematic review and network meta-analysis with evidence certainty assessment. Frontiers in pharmacology 82.8 15 A PDGFRB-CD44-MIF crosstalk promotes cancer-associated cellular phenotypes in ATRT-TYR/MYC cell lines. Frontiers in oncology 51.6 16 Case Report: Two cases of secondary malignant neoplasms following treatment in pediatric patients. Frontiers in pediatrics 61.14 17 Guanfacine and HCN channels: bridging neuroinflammation and prefrontal cortex function in autism spectrum disorder. Frontiers in molecular neuroscience 62.9 18 Clinical Outcomes and New Treatments in Pediatric Brain Tumors. Current oncology (Toronto, Ont.) 52.74 19 Quality of Life in Ukrainian Children and Adolescents with Cancer Relocated to Switzerland During the Russian-Ukrainian War: An Exploratory Multicenter Study. Current oncology (Toronto, Ont.) 59.9 20 Vitamin D and Gastric Cancer: A Systematic Review and Meta-Analysis. Medical sciences (Basel, Switzerland) 73.0 21 "If I want to tap into a cord blood bank later, I felt that I should do my part and donate": Mutualism in women's accounts of umbilical cord blood donation. Social science & medicine (1982) 56.0 22 Metabolic profiling of CAR T-cells in patients reveals a shift toward amino acid-supported OXPHOS and informs transporter engineering. Research square 58.8 23 Oncohistone inhibition reshapes tumor-microenvironment communication in Diffuse Midline Glioma (DMG). bioRxiv : the preprint server for biology 58.8 24 Prenatally Detected Neonatal Neuroblastoma Associated with Achondroplasia and an SDHA Variant. Neurology international 62.8 25 Preclinical evaluation of ixazomib for high-risk pediatric brain tumors. bioRxiv : the preprint server for biology 59.7 26 Fusion Oncoprotein EWSR1::FLI1 Invades Nucleosomes at Consensus ETS Motifs and GGAA Microsatellites. bioRxiv : the preprint server for biology 56.0 27 Genomic Characterization of RTK-RAS Pathway Alterations in Juvenile Myelomonocytic Leukemia Through Whole-Exome Sequencing. Medical sciences (Basel, Switzerland) 65.9 28 Management of intractable emergence agitation with emotional and behavioural disinhibition in a child with anxiety requiring multiple anaesthetics. Anaesthesia reports 60.0 29 [Spitz tumors]. Pathologie (Heidelberg, Germany) 56.0 30 Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas. Pituitary 61.4 31 Successful Cytotoxic Chemotherapy-Free Bridging to Hematopoietic Stem Cell Transplantation With Dasatinib and Prednisolone/Blinatumomab for Relapsed Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Pediatric blood & cancer 55.06 32 Physical activity and exercise in pediatric oncology: conceptual distinctions and clinical implications. Turkish journal of physical medicine and rehabilitation 62.0
PATIENT-FRIENDLY SUMMARY

Is Rotationplasty Still a Reasonable Reconstruction Option for Patients With a Femoral Bone Sarcoma? A Comparative Study of Patients With a Minimum of 20 Years of Follow-up After Rotationplasty and Lower Extremity Amputation.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic